A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

Focusing on GLP-1 medications like semaglutide and tripeptide, Clinic Secret targets one of the most promising approaches to weight loss in recent years. These medications mimic a natural hormone ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

Recent research into newer treatments for type 2 diabetes recognized the role that incretin hormones play in ... in this process are glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...